|
Delayed
NYSE
12:51:15 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 0.1754 USD | -0.93% |
|
+6.24% | -70.07% |
| 08-20 | Top Premarket Decliners | MT |
| 08-13 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.93% | +6.24% | -10.74% | -73.02% | -70.07% | -90.96% | -97.19% | -99.76% | -99.78% | 2.6M | |
| +0.06% | +7.20% | +3.13% | +57.21% | +85.29% | +54.04% | +111.13% | +9.49% | - | 74.27B | |
| -2.29% | -1.51% | -3.29% | +2.80% | +16.60% | +33.30% | +75.15% | +209.56% | +5,416.83% | 61.21B | |
| +0.28% | +7.27% | +3.53% | +71.76% | +67.94% | +31.74% | +23.80% | -56.54% | - | 27.55B | |
| -3.24% | -4.01% | -5.10% | +15.18% | -32.39% | -19.07% | +356.40% | +326.61% | +697.15% | 26.38B | |
| -1.61% | +3.73% | -11.89% | +9.69% | +4.42% | +1.15% | -3.60% | -71.84% | - | 25.34B | |
| +0.57% | +3.66% | +8.52% | +34.15% | +13.07% | +25.59% | -9.08% | -18.92% | +100.52% | 20.84B | |
| -1.47% | +4.46% | -10.22% | +23.09% | +23.15% | -8.09% | +513.33% | - | - | 14.94B | |
| +1.29% | -2.49% | -16.07% | +19.03% | +177.32% | +163.31% | +333.06% | +1,388.09% | +653.35% | 15.17B | |
| -3.08% | -0.75% | +3.31% | +9.77% | +28.58% | +41.56% | +158.16% | +174.91% | +278.48% | 14.41B | |
| -4.41% | -5.97% | +27.79% | +14.16% | -6.99% | -15.05% | +747.25% | +202.36% | +86.34% | 13.66B | |
| -2.69% | -4.53% | -1.33% | -1.61% | -13.26% | +13.94% | +234.66% | +494.56% | +4,235.97% | 11.99B | |
| +1.67% | +2.36% | +8.03% | +17.54% | -13.72% | -25.57% | +160.00% | +133.25% | - | 11.26B | |
| -6.97% | +1.51% | -23.00% | -16.41% | +0.59% | +105.49% | +150.41% | +3.22% | +825.00% | 10.15B | |
| -4.05% | -6.38% | -15.73% | -18.81% | +2.23% | +33.80% | +116.68% | +93.28% | +641.55% | 9.4B | |
| -6.73% | +9.80% | +14.58% | +18.65% | +338.64% | +235.33% | +439.44% | -18.91% | - | 9.85B | |
| -5.93% | -5.68% | -10.41% | +6.68% | +20.13% | +67.21% | +9.03% | +111.73% | - | 8.78B | |
| -0.69% | +4.44% | -0.13% | +18.05% | +9.44% | -24.23% | +94.81% | -23.20% | - | 8.71B | |
| -6.09% | -5.08% | -18.86% | -10.83% | +164.16% | +440.20% | +644.11% | -55.45% | -46.66% | 8.11B | |
| -4.71% | -0.93% | +5.51% | +15.54% | +4.79% | +135.93% | +436.07% | - | - | 7.06B | |
| Average | -2.50% | +3.02% | -2.62% | +10.63% | +41.00% | +59.98% | +224.68% | +155.69% | +1,162.61% | 18.95B | |
| Weighted average by Cap. | -1.76% | +2.76% | -1.24% | +23.69% | +44.26% | +48.09% | +180.99% | +149.01% | +2,257.84% |
- Stock Market
- Stocks
- MTNB Stock
- Sector Matinas BioPharma
Select your edition
All financial news and data tailored to specific country editions
